OrigaRGalanelloRGanzT. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica2007; 92: 583–588.
2.
AessoposATsironiMAndreopoulosAFarmakisD. Heart disease in thalassemia intermedia. Hemoglobin2009; 33(Suppl 1): S170–S176.
3.
MusallamKMCappelliniMDWoodJCTaherAT. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. Blood Rev2012; 26(Suppl 1): S16–S19.
4.
GanzTNemethE. Hepcidin and iron homeostasis. Biochimia Biophysica Acta2012; 1823: 1434–1443.
5.
ParkCValoreEWaringAGanzT. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem2001; 276: 7806–7810.
6.
NemethEGanZ. Hepcidin and iron-loading anemias. Haematologica2006; 91: 727–732.
7.
PasrichaSFrazerDBowdenDAndersonG. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with beta-thalassemia major: a longitudinal study. Blood2013; 122: 124–133.
8.
PrezaGRuchalaPPinonR. Minihepcidins are rationally designed small peptides that mimic hepidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest2011; 121: 4880–4888.
